Dr. Nerses Sanossian, MD

Dr. Sanossian practices at Los Angeles General Medical Center in Los Angeles, California, part of County of Los Angeles.

Dr. Sanossian's NPI, 1194741397, was assigned on July 14, 2006. Dr. Sanossian graduated from Albert Einstein College of Medicine in 2000. Dr. Sanossian holds California license A87549.

Dr. Sanossian's primary practice is Los Angeles General Medical Center, at 2051 Marengo St, Room C2K100, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 226-2800.

Dr. Sanossian's primary practice is Los Angeles General Medical Center in Los Angeles, California, part of County of Los Angeles. Dr. Sanossian is also affiliated with Keck Hospital of USC. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Sanossian to 1 more group practice or clinic and 1 other site, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sanossian practices, 4 sites in all. Vendor and product names are available with a free account.

Neurocritical care is Dr. Sanossian's primary specialty in the NPI Registry, under taxonomy code 2084A2900X. Dr. Sanossian is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Sanossian's licenses on file in 9 states: California, Michigan, New York, Indiana, Kentucky, New Jersey, Nevada, Oklahoma and Arkansas.

Dmand AI lists acute mini-stroke (TIA), carpal tunnel syndrome, cerebrovascular disease and stroke among the conditions Dr. Sanossian treats.

CMS data shows 64 Medicare services from Dr. Sanossian across 2 procedure codes in 2024, all of them office visits, for 73 Medicare patients. Medicare paid $3,785 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 73 Medicare patients who saw Dr. Sanossian in 2024. The largest group is 75 to 84, with 30 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sanossian's median patient age at 65, with 47% women.

In 2024, Dr. Sanossian wrote 81 Medicare Part D claims for 19 patients. 95% of them were for generic drugs. CMS names the drug for 28 of them, across 2 drugs with 11 or more claims each, at $119 in total drug cost. In 2022, CMS named 62 claims across 5 drugs.

Dr. Sanossian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sanossian as offering telehealth.

Dmand AI links 18 papers to Dr. Sanossian, published from 2008 to 2023. Dr. Sanossian's most frequent co-authors are David Sigmund Liebeskind, MD, William Jacob Mack, MD and Jeffrey Lawrence Saver, MD.

Dmand AI links Dr. Sanossian to 3 clinical trials. Conditions studied include Stroke, Cerebrovascular Disorders and Cerebral Hemorrhage. University of California, Los Angeles sponsors the most, 2.

CMS Open Payments shows 261 general payments to Dr. Sanossian from 8 drug and device companies from 2016 to 2024. Speaker and faculty fees make up the largest share, 71% of the total. Genentech, Inc. paid the most, $231,106. It also lists 34 research payments totaling $51,669 from 2016 to 2020.

Dmand AI lists 10 awards for Dr. Sanossian, most recently Stroke Progress and Innovation Award in 2011.

Dr. Sanossian graduated from Albert Einstein College of Medicine in 2000. Dr. Sanossian is a member of AAN and AHA.

Dr. Sanossian is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.